These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 15953839)
1. Advances in monoclonal antibody technology: genetic engineering of mice, cells, and immunoglobulins. Peterson NC ILAR J; 2005; 46(3):314-9. PubMed ID: 15953839 [TBL] [Abstract][Full Text] [Related]
2. Antibody production without animals. Stadler BM Dev Biol Stand; 1999; 101():45-8. PubMed ID: 10566774 [TBL] [Abstract][Full Text] [Related]
3. Of mice and men: hybridoma and recombinant antibodies. Little M; Kipriyanov SM; Le Gall F; Moldenhauer G Immunol Today; 2000 Aug; 21(8):364-70. PubMed ID: 10916138 [TBL] [Abstract][Full Text] [Related]
4. [Immunotargeting of tumors: state of the art and prospects in 2000]. Pèlegrin A; Xavier F; Barbet J; Bartholeyns J; Baty D; Buchegger F; Chatal JF; Dufief F; Gurreau D; Gruaz-Guyon A; Lamotte D; Leserman L; Mach JP; Robert B; Saccavini JC; Teillaud JL; Teulon I Bull Cancer; 2000 Nov; 87(11):777-91. PubMed ID: 11125287 [TBL] [Abstract][Full Text] [Related]
5. Genetically engineered antibody molecules: new tools for cancer therapy. Morrison SL; Wims LA; Oi VT Cancer Invest; 1988; 6(2):185-92. PubMed ID: 3288296 [No Abstract] [Full Text] [Related]
6. Heterologous protein production in transgenic plants. Whitelam GC; Cockburn B; Gandecha AR; Owen MR Biotechnol Genet Eng Rev; 1993; 11():1-29. PubMed ID: 7840843 [No Abstract] [Full Text] [Related]
7. Effects of genetic engineering on the pharmacokinetics of antibodies. Colcher D; Goel A; Pavlinkova G; Beresford G; Booth B; Batra SK Q J Nucl Med; 1999 Jun; 43(2):132-9. PubMed ID: 10429508 [TBL] [Abstract][Full Text] [Related]
8. Production of a diverse repertoire of human antibodies in genetically engineered mice. Ishida I; Yoshida H; Tomizuka K Microbiol Immunol; 1998; 42(3):143-50. PubMed ID: 9570278 [No Abstract] [Full Text] [Related]
10. Production of antibody fragments in a bioreactor. Hellebust H Methods Mol Biol; 2003; 207():437-41. PubMed ID: 12412490 [No Abstract] [Full Text] [Related]
11. Engineered single chain antibody fragments for radioimmunotherapy. Huhalov A; Chester KA Q J Nucl Med Mol Imaging; 2004 Dec; 48(4):279-88. PubMed ID: 15640791 [TBL] [Abstract][Full Text] [Related]
12. Production of antibodies and antibody fragments in plants. Peeters K; De Wilde C; De Jaeger G; Angenon G; Depicker A Vaccine; 2001 Mar; 19(17-19):2756-61. PubMed ID: 11257420 [TBL] [Abstract][Full Text] [Related]
13. The next generation of antibodies: production of recombinant antibodies or fragments derived thereof. de Geus B Res Immunol; 1998; 149(6):587-9. PubMed ID: 9835422 [No Abstract] [Full Text] [Related]
14. Human monoclonal antibodies and engineered antibodies in the management of cancer. James K Semin Cancer Biol; 1990 Jun; 1(3):243-53. PubMed ID: 2103499 [TBL] [Abstract][Full Text] [Related]
15. Recent advances in the large-scale production of antibody fragments using lower eukaryotic microorganisms. Frenken LG; Hessing JG; Van den Hondel CA; Verrips CT Res Immunol; 1998; 149(6):589-99. PubMed ID: 9835423 [No Abstract] [Full Text] [Related]
17. [Production of phage-displayed single chain variable fragments of monoclonal antibody MGb1]. He F; Chen B; Nie Y; Han Z; Qiao T; Fan D Zhonghua Nei Ke Za Zhi; 2000 Sep; 39(9):585-7. PubMed ID: 11798521 [TBL] [Abstract][Full Text] [Related]
18. Human cancer detection and immunotherapy with conjugated and non-conjugated monoclonal antibodies. Bodey B; Siegel SE; Kaiser HE Anticancer Res; 1996; 16(2):661-74. PubMed ID: 8687112 [TBL] [Abstract][Full Text] [Related]
19. Antibody discovery: the use of transgenic mice to generate human monoclonal antibodies for therapeutics. Kellermann SA; Green LL Curr Opin Biotechnol; 2002 Dec; 13(6):593-7. PubMed ID: 12482519 [TBL] [Abstract][Full Text] [Related]